<PAGE> 1
-----------------------------------------------------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
----------------------
Form 20-F/A-1
/ / Registration Statement Pursuant to Section 12(b) or 12(g) of the
Securities Exchange Act of 1934
or
/X/ Annual Report Pursuant to Section 13 or 15(d) of the Securities
Exchange of 1934
or
/ / Transition Report Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
For the Transition period from ___________ to ___________
Commission file number 001-11145
BIOVAIL CORPORATION INTERNATIONAL
(Exact Name of Registrant as Specified in its Charter)
NOT APPLICABLE
(Translation of Registrant's Name into English)
CANADA
(Jurisdiction of incorporation or organization)
2488 DUNWIN DRIVE
MISSISSAUGA, ONTARIO
CANADA, L5L 1J9
(Address of principal executive offices)
Securities registered or to be registered pursuant to Section 12(b) of the Act:
NONE
COMMON SHARES WITHOUT PAR VALUE
(Title of Class)
AMERICAN STOCK EXCHANGE
(Name of exchange on which registered)
Securities registered or to be registered pursuant to Section 12(g) of the Act:
Securities for which there is a reporting obligation pursuant to Section 15(d)
of the Act: NONE
Number of outstanding shares of the registrant's common stock as of December
31, 1995: 25,327,092 (after giving effect to a 3-for-1 stock split in January,
1996)
Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.
Yes X No _____
Indicate by check mark which financial statement item the registrant has
elected to follow.
Item 17 X Item 18 _____
<PAGE> 2
TABLE OF CONTENTS
GENERAL INFORMATION
PAGE
PART I
(Not Applicable)
PART II
(Not Applicable)
PART III
(Not Applicable)
PART IV
Item 19. Financial Statements and Exhibits . . . . . . . . . . . . . . . . ___
SIGNATURES
<PAGE> 3
D. EXHIBITS FILED WITH THIS SUBMISSION
NUMBER DESCRIPTION
21.1 Subsidiaries of the Registrant
Attached is Exhibit 21.1 of the Form 20-F for the
year ended December 31, 1995. The list of subsidiaries of the
Registrant reflects the September 9, 1996 formation of Biovail
Americas Corp., a Delaware corporation and a wholly-owned
subsidiary of the Registrant.
<PAGE> 4
SIGNATURES
Pursuant to the requirements of Section 12 of the Securities Exchange Act of
1934, the registrant certifies that it meets all of the requirements for filing
this Form 20-F/A-1 and has duly caused this Annual Report to be signed on its
behalf by the undersigned, thereunto duly authorized.
BIOVAIL CORPORATION INTERNATIONAL
/s/ Robert A. Podruzny
--------------------------------------
Robert A. Podruzny
Vice President - Finance and
Chief Financial Officer
Date: September 12, 1996
<PAGE> 5
EXHIBIT INDEX
-------------
NUMBER DESCRIPTION
------ -----------
21.1 Subsidiaries of the Registrant
<PAGE> 1
EXHIBIT 21.1
Biovail Corporation International:
Subsidiaries:
1. Biovail SA, a Switzerland corporation;
2. Biosytes N.V., a Netherlands Antilles corporation;
3. Biovail Laboratories Incorporated, a Barbados corporation;
4. Biovail [U.K.] Ltd., a United Kingdom corporation; and
5. Biovail Americas Corp. a Delaware corporation.
